How big is Samyang Biopharm USA, Inc.'s plan?

Samyang Biopharm USA, Inc.'s plan reported $207K in assets and 1 participants for 2024.

Original filing (PDF)20250702134400NAL0019907696001

Samyang Biopharm USA, Inc.

Name: Samyang Biopharm USA, Inc. — Samyang 401(k) Plan, Form 5500 (2024)
Creator: Samyang Biopharm USA, Inc.
License: https://www.usa.gov/government-works

Form 5500-SF

FILING_RECEIVED

Samyang 401(k) Plan

401(k) retirement plan · Samyang Biopharm USA, Inc.'s Samyang 401(k) Plan held $207K in plan assets for 1 participants in 2024.

Active participants

Accounts w/ balance

Plan assets (EOY)

$207K

Net assets (EOY)

$207K

People on this filing

Seong IL KIM signed Samyang Biopharm USA, Inc.'s 2024 Form 5500 as plan administrator.

Seong IL KIM — Plan Administrator — Form 5500 signer

Get verified email & phone for these signers

Signer names are public record from the Form 5500 e-signature.

Plan identifiers

Samyang Biopharm USA, Inc.'s EIN is 73-1639424.

EIN 73-1639424

Plan number 001

Plan year 2024

ACK ID 20250702134400NAL0019907696001

Official Form 5500 document

Download the official 2024 Form 5500 (PDF) for Samyang Biopharm USA, Inc. from the U.S. Department of Labor's EFAST2 system.

Download the official 2024 Form 5500 (PDF)

Plan features

Samyang Biopharm USA, Inc.'s plan includes profit-sharing, a 401(k) feature, ERISA 404(c) participant direction, a default investment (QDIA).

Decision-maker contacts

One unlock reveals every key decision-maker — plan signer, CFO, HR & Benefits — with verified email + LinkedIn for SAMYANG BIOPHARM USA, INC..

Finding similar companies…

Plan health score

Top-tier plan health

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 70% of scoring inputs for this filing.

Compliance & integrity

100

Total plan cost

n/a

Plan health

Vendor & structure

100

Helping the score

Cost not scored — no comparable Schedule H expense data for this cohort.
High average account balance (88th percentile).
High account-holder ratio — balance-holders per active participant in the top 15% of peers (96th percentile).

Plan sponsor

Name

SAMYANG BIOPHARM USA, INC.

EIN

all filings

Address

BUILDING 600/700 · ONE KENDALL SQUARE SUITE 6-202 · CAMBRIDGE, MA · 02139

Phone

(617) 256-0189

Industry

Professional & Technical Services

Plan administrator